v3.25.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jan. 13, 2025
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Business combination related cost         $ 422,386   $ 527,145
Other receivables   $ 176,220   $ 176,220 176,220   138,046
Loss on issuance of forward purchase agreement $ 1,929,656   (1,929,656)  
Change in fair value of forward purchase agreement   755,837 1,123,154 1,123,154  
Forward purchase agreement   $ 806   $ 806 806    
Shenzhen Qianzhi Bio Technology Co Ltd [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Business combination related cost         384,212   $ 389,099
Business Combination Marketing Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Business combination related cost         $ 2,415,000    
Percentage of gross proceeds of initial public offering   3.50%   3.50% 3.50%    
Percentage of service fee of total consideration payable   1.00%   1.00% 1.00%    
Forward Purchase Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Prepaid forward purchase shares 500,000